Receptor Tyrosine Protein Kinase ERBB 3 Market - Global Outlook and Forecast 2021-2027

Code: RW00014560242
Market Monitor Global
Oct-2021
Life Sciences
109 Pages

This report contains market size and forecasts of Receptor Tyrosine Protein Kinase ERBB 3 in global, including the following market information:
Global Receptor Tyrosine Protein Kinase ERBB 3 Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Receptor Tyrosine Protein Kinase ERBB 3 Market Sales, 2016-2021, 2022-2027, (K Pcs)
Global top five Receptor Tyrosine Protein Kinase ERBB 3 companies in 2020 (%)
The global Receptor Tyrosine Protein Kinase ERBB 3 market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Receptor Tyrosine Protein Kinase ERBB 3 manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Receptor Tyrosine Protein Kinase ERBB 3 Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Receptor Tyrosine Protein Kinase ERBB 3 Market Segment Percentages, By Type, 2020 (%)
BA-0702
CDX-3379
Elgemtumab
ETBX-031
Others

Global Receptor Tyrosine Protein Kinase ERBB 3 Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Receptor Tyrosine Protein Kinase ERBB 3 Market Segment Percentages, By Application, 2020 (%)
Non-Small Cell Carcinoma
Solid Tumor
Melanoma
Colorectal Cancer
Others

Global Receptor Tyrosine Protein Kinase ERBB 3 Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Receptor Tyrosine Protein Kinase ERBB 3 Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Receptor Tyrosine Protein Kinase ERBB 3 revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Receptor Tyrosine Protein Kinase ERBB 3 revenues share in global market, 2020 (%)
Key companies Receptor Tyrosine Protein Kinase ERBB 3 sales in global market, 2016-2021 (Estimated), (K Pcs)
Key companies Receptor Tyrosine Protein Kinase ERBB 3 sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca Plc
AVEO Pharmaceuticals, Inc.
Etubics Corporation
F. Hoffmann-La Roche Ltd.
GamaMabs Pharma S.A.
GlaxoSmithKline Plc
Hanmi Pharmaceuticals, Co. Ltd.
ImmunoGen, Inc.
Kolltan Pharmaceuticals, Inc.
Merrimack Pharmaceuticals, Inc.
Merus B.V.
Novartis AG
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Sihuan Pharmaceutical Holdings Group Ltd.
Sorrento Therapeutics, Inc.
Symphogen A/S
Takis S.r.l.

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Receptor Tyrosine Protein Kinase ERBB 3 Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Receptor Tyrosine Protein Kinase ERBB 3 Overall Market Size
2.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size: 2021 VS 2027
2.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Receptor Tyrosine Protein Kinase ERBB 3 Players in Global Market
3.2 Top Global Receptor Tyrosine Protein Kinase ERBB 3 Companies Ranked by Revenue
3.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Companies
3.4 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Companies
3.5 Global Receptor Tyrosine Protein Kinase ERBB 3 Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Receptor Tyrosine Protein Kinase ERBB 3 Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Receptor Tyrosine Protein Kinase ERBB 3 Product Type
3.8 Tier 1, Tier 2 and Tier 3 Receptor Tyrosine Protein Kinase ERBB 3 Players in Global Market
3.8.1 List of Global Tier 1 Receptor Tyrosine Protein Kinase ERBB 3 Companies
3.8.2 List of Global Tier 2 and Tier 3 Receptor Tyrosine Protein Kinase ERBB 3 Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size Markets, 2021 & 2027
4.1.2 BA-0702
4.1.3 CDX-3379
4.1.4 Elgemtumab
4.1.5 ETBX-031
4.1.6 Others
4.2 By Type - Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue & Forecasts
4.2.1 By Type - Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue, 2016-2021
4.2.2 By Type - Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue, 2022-2027
4.2.3 By Type - Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share, 2016-2027
4.3 By Type - Global Receptor Tyrosine Protein Kinase ERBB 3 Sales & Forecasts
4.3.1 By Type - Global Receptor Tyrosine Protein Kinase ERBB 3 Sales, 2016-2021
4.3.2 By Type - Global Receptor Tyrosine Protein Kinase ERBB 3 Sales, 2022-2027
4.3.3 By Type - Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share, 2016-2027
4.4 By Type - Global Receptor Tyrosine Protein Kinase ERBB 3 Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2021 & 2027
5.1.2 Non-Small Cell Carcinoma
5.1.3 Solid Tumor
5.1.4 Melanoma
5.1.5 Colorectal Cancer
5.1.6 Others
5.2 By Application - Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue & Forecasts
5.2.1 By Application - Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue, 2016-2021
5.2.2 By Application - Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue, 2022-2027
5.2.3 By Application - Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share, 2016-2027
5.3 By Application - Global Receptor Tyrosine Protein Kinase ERBB 3 Sales & Forecasts
5.3.1 By Application - Global Receptor Tyrosine Protein Kinase ERBB 3 Sales, 2016-2021
5.3.2 By Application - Global Receptor Tyrosine Protein Kinase ERBB 3 Sales, 2022-2027
5.3.3 By Application - Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share, 2016-2027
5.4 By Application - Global Receptor Tyrosine Protein Kinase ERBB 3 Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2021 & 2027
6.2 By Region - Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue & Forecasts
6.2.1 By Region - Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue, 2016-2021
6.2.2 By Region - Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue, 2022-2027
6.2.3 By Region - Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share, 2016-2027
6.3 By Region - Global Receptor Tyrosine Protein Kinase ERBB 3 Sales & Forecasts
6.3.1 By Region - Global Receptor Tyrosine Protein Kinase ERBB 3 Sales, 2016-2021
6.3.2 By Region - Global Receptor Tyrosine Protein Kinase ERBB 3 Sales, 2022-2027
6.3.3 By Region - Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Receptor Tyrosine Protein Kinase ERBB 3 Revenue, 2016-2027
6.4.2 By Country - North America Receptor Tyrosine Protein Kinase ERBB 3 Sales, 2016-2027
6.4.3 US Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2016-2027
6.4.4 Canada Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2016-2027
6.4.5 Mexico Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue, 2016-2027
6.5.2 By Country - Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales, 2016-2027
6.5.3 Germany Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2016-2027
6.5.4 France Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2016-2027
6.5.5 U.K. Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2016-2027
6.5.6 Italy Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2016-2027
6.5.7 Russia Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2016-2027
6.5.8 Nordic Countries Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2016-2027
6.5.9 Benelux Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Receptor Tyrosine Protein Kinase ERBB 3 Revenue, 2016-2027
6.6.2 By Region - Asia Receptor Tyrosine Protein Kinase ERBB 3 Sales, 2016-2027
6.6.3 China Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2016-2027
6.6.4 Japan Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2016-2027
6.6.5 South Korea Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2016-2027
6.6.6 Southeast Asia Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2016-2027
6.6.7 India Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Receptor Tyrosine Protein Kinase ERBB 3 Revenue, 2016-2027
6.7.2 By Country - South America Receptor Tyrosine Protein Kinase ERBB 3 Sales, 2016-2027
6.7.3 Brazil Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2016-2027
6.7.4 Argentina Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales, 2016-2027
6.8.3 Turkey Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2016-2027
6.8.4 Israel Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2016-2027
6.8.5 Saudi Arabia Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2016-2027
6.8.6 UAE Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 AstraZeneca Plc
7.1.1 AstraZeneca Plc Corporate Summary
7.1.2 AstraZeneca Plc Business Overview
7.1.3 AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.1.4 AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2016-2021)
7.1.5 AstraZeneca Plc Key News
7.2 AVEO Pharmaceuticals, Inc.
7.2.1 AVEO Pharmaceuticals, Inc. Corporate Summary
7.2.2 AVEO Pharmaceuticals, Inc. Business Overview
7.2.3 AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.2.4 AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2016-2021)
7.2.5 AVEO Pharmaceuticals, Inc. Key News
7.3 Etubics Corporation
7.3.1 Etubics Corporation Corporate Summary
7.3.2 Etubics Corporation Business Overview
7.3.3 Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.3.4 Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2016-2021)
7.3.5 Etubics Corporation Key News
7.4 F. Hoffmann-La Roche Ltd.
7.4.1 F. Hoffmann-La Roche Ltd. Corporate Summary
7.4.2 F. Hoffmann-La Roche Ltd. Business Overview
7.4.3 F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.4.4 F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2016-2021)
7.4.5 F. Hoffmann-La Roche Ltd. Key News
7.5 GamaMabs Pharma S.A.
7.5.1 GamaMabs Pharma S.A. Corporate Summary
7.5.2 GamaMabs Pharma S.A. Business Overview
7.5.3 GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.5.4 GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2016-2021)
7.5.5 GamaMabs Pharma S.A. Key News
7.6 GlaxoSmithKline Plc
7.6.1 GlaxoSmithKline Plc Corporate Summary
7.6.2 GlaxoSmithKline Plc Business Overview
7.6.3 GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.6.4 GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2016-2021)
7.6.5 GlaxoSmithKline Plc Key News
7.7 Hanmi Pharmaceuticals, Co. Ltd.
7.7.1 Hanmi Pharmaceuticals, Co. Ltd. Corporate Summary
7.7.2 Hanmi Pharmaceuticals, Co. Ltd. Business Overview
7.7.3 Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.4.4 Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2016-2021)
7.7.5 Hanmi Pharmaceuticals, Co. Ltd. Key News
7.8 ImmunoGen, Inc.
7.8.1 ImmunoGen, Inc. Corporate Summary
7.8.2 ImmunoGen, Inc. Business Overview
7.8.3 ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.8.4 ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2016-2021)
7.8.5 ImmunoGen, Inc. Key News
7.9 Kolltan Pharmaceuticals, Inc.
7.9.1 Kolltan Pharmaceuticals, Inc. Corporate Summary
7.9.2 Kolltan Pharmaceuticals, Inc. Business Overview
7.9.3 Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.9.4 Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2016-2021)
7.9.5 Kolltan Pharmaceuticals, Inc. Key News
7.10 Merrimack Pharmaceuticals, Inc.
7.10.1 Merrimack Pharmaceuticals, Inc. Corporate Summary
7.10.2 Merrimack Pharmaceuticals, Inc. Business Overview
7.10.3 Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.10.4 Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2016-2021)
7.10.5 Merrimack Pharmaceuticals, Inc. Key News
7.11 Merus B.V.
7.11.1 Merus B.V. Corporate Summary
7.11.2 Merus B.V. Receptor Tyrosine Protein Kinase ERBB 3 Business Overview
7.11.3 Merus B.V. Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.11.4 Merus B.V. Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2016-2021)
7.11.5 Merus B.V. Key News
7.12 Novartis AG
7.12.1 Novartis AG Corporate Summary
7.12.2 Novartis AG Receptor Tyrosine Protein Kinase ERBB 3 Business Overview
7.12.3 Novartis AG Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.12.4 Novartis AG Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2016-2021)
7.12.5 Novartis AG Key News
7.13 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
7.13.1 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Corporate Summary
7.13.2 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Business Overview
7.13.3 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.13.4 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2016-2021)
7.13.5 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Key News
7.14 Sihuan Pharmaceutical Holdings Group Ltd.
7.14.1 Sihuan Pharmaceutical Holdings Group Ltd. Corporate Summary
7.14.2 Sihuan Pharmaceutical Holdings Group Ltd. Business Overview
7.14.3 Sihuan Pharmaceutical Holdings Group Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.14.4 Sihuan Pharmaceutical Holdings Group Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2016-2021)
7.14.5 Sihuan Pharmaceutical Holdings Group Ltd. Key News
7.15 Sorrento Therapeutics, Inc.
7.15.1 Sorrento Therapeutics, Inc. Corporate Summary
7.15.2 Sorrento Therapeutics, Inc. Business Overview
7.15.3 Sorrento Therapeutics, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.15.4 Sorrento Therapeutics, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2016-2021)
7.15.5 Sorrento Therapeutics, Inc. Key News
7.16 Symphogen A/S
7.16.1 Symphogen A/S Corporate Summary
7.16.2 Symphogen A/S Business Overview
7.16.3 Symphogen A/S Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.16.4 Symphogen A/S Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2016-2021)
7.16.5 Symphogen A/S Key News
7.17 Takis S.r.l.
7.17.1 Takis S.r.l. Corporate Summary
7.17.2 Takis S.r.l. Business Overview
7.17.3 Takis S.r.l. Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.17.4 Takis S.r.l. Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2016-2021)
7.17.5 Takis S.r.l. Key News
8 Global Receptor Tyrosine Protein Kinase ERBB 3 Production Capacity, Analysis
8.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Production Capacity, 2016-2027
8.2 Receptor Tyrosine Protein Kinase ERBB 3 Production Capacity of Key Manufacturers in Global Market
8.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Receptor Tyrosine Protein Kinase ERBB 3 Supply Chain Analysis
10.1 Receptor Tyrosine Protein Kinase ERBB 3 Industry Value Chain
10.2 Receptor Tyrosine Protein Kinase ERBB 3 Upstream Market
10.3 Receptor Tyrosine Protein Kinase ERBB 3 Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Receptor Tyrosine Protein Kinase ERBB 3 Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Receptor Tyrosine Protein Kinase ERBB 3 in Global Market
Table 2. Top Receptor Tyrosine Protein Kinase ERBB 3 Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Share by Companies, 2016-2021
Table 5. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Companies, (K Pcs), 2016-2021
Table 6. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Receptor Tyrosine Protein Kinase ERBB 3 Price (2016-2021) & (USD/Pcs)
Table 8. Global Manufacturers Receptor Tyrosine Protein Kinase ERBB 3 Product Type
Table 9. List of Global Tier 1 Receptor Tyrosine Protein Kinase ERBB 3 Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Receptor Tyrosine Protein Kinase ERBB 3 Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

AstraZeneca Plc
AVEO Pharmaceuticals, Inc.
Etubics Corporation
F. Hoffmann-La Roche Ltd.
GamaMabs Pharma S.A.
GlaxoSmithKline Plc
Hanmi Pharmaceuticals, Co. Ltd.
ImmunoGen, Inc.
Kolltan Pharmaceuticals, Inc.
Merrimack Pharmaceuticals, Inc.
Merus B.V.
Novartis AG
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Sihuan Pharmaceutical Holdings Group Ltd.
Sorrento Therapeutics, Inc.
Symphogen A/S
Takis S.r.l.

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE